This study reported for the first time that genetic modulation of ABCG1 was intimately linked to fat mass growth and obesity in humans suggesting that ABCG1 might represent a potential therapeutic target in obesity [125]. The gene discussed is ABCG1; the disease is obesity due to melanocortin 4 receptor deficiency.